
Astellas Pharma
Dedicated to the development of high-quality peer-reviewed publications covering Astellas products that are compliant with applicable regulations and guidance.
Enterprise value
$22.7b
Share price
€9.16 YPH.F
Recent deals
Corporate Venture Fund
No columns specified